Evidence map›Paper›PMID 31905492›Full record

ArticleTurkish journal of medical sciences2020

Avascular necrosis less frequently found in systemic lupus erythematosus patients with the use of alternate day corticosteroid

Ismail Doğan, Umut Kalyoncu, Levent Kiliç, Ali Akdoğan, Ömer Karadağ, Sedat Kiraz, Şule A Bilgen, Ihsan Ertenli

Open access · bronzeAbstract read
In one paragraph

Article in Turkish journal of medical sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 2 pooled it
1.4field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 2 syntheses or guidelines pooled it, 12 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Ismail DoğanDivision of Rheumatology, Department of Internal Medicine, Yıldırım Beyazıt University, Ankara, TurkeyORCID 0000-0002-7603-9484
Umut KalyoncuDivision of Rheumatology, Department of Internal Medicine, Hacettepe University, Ankara, TurkeyORCID 0000-0001-7129-2109
Levent KiliçDivision of Rheumatology, Department of Internal Medicine, Hacettepe University, Ankara, TurkeyORCID 0000-0003-1064-9690
Ali AkdoğanDivision of Rheumatology, Department of Internal Medicine, Hacettepe University, Ankara, TurkeyORCID 0000-0001-7592-3844
Ömer KaradağDivision of Rheumatology, Department of Internal Medicine, Hacettepe University, Ankara, TurkeyORCID 0000-0002-3443-3117
Sedat KirazDivision of Rheumatology, Department of Internal Medicine, Hacettepe University, Ankara, TurkeyORCID 0000-0003-2802-6061
Şule A BilgenDivision of Rheumatology, Department of Internal Medicine, Hacettepe University, Ankara, TurkeyORCID 0000-0001-8208-1585
Ihsan ErtenliDivision of Rheumatology, Department of Internal Medicine, Hacettepe University, Ankara, TurkeyORCID 0000-0002-3904-0769
Hacettepe University · TRAnkara University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background/aim: Avascular necrosis (AVN) is the death of bone due to compromise of blood flow. The etiology of AVN is multifactorial; corticosteroid usage is the second most significant factor after trauma, and systemic lupus erythematosus (SLE) is the most common underlying disease. The objective of this study was to assess the factors of AVN in SLE patients. Materials and methods: The study included 127 patients with SLE who fulfilled 1997 American College of Rheumatology (ACR) revised criteria. Demographic data, age at SLE diagnosis, disease duration, disease activity, body mass index, clinical findings, antiphospholipid syndrome, steroid usage, dose and duration, comorbid diseases, and smoking history were recorded. Results: AVN was found in 11 of 127 (8.7%) SLE patients. Hyperlipidemia (P < 0.001), cushingoid body habitus (P < 0.001), and proteinuria (P = 0.013) were found at higher rates in the AVN group. All of the 11 AVN cases had osteoporosis (P < 0.02). In multivariate regression analysis, daily steroid usage was the only factor for development of AVN in SLE. Conclusion: The hypothesis of our study was that an alternate day steroid regimen may decrease AVN frequency in SLE patients.

Indexed as

Adrenal Cortex HormonesDrug Administration ScheduleLupus Erythematosus, SystemicOsteonecrosisRisk FactorsAdrenal Cortex Hormonesalternate day steroid usageAvascular necrosissystemic lupus erythematosus.

Identifiers

PMID31905492
PMCPMC7080371
OpenAlexW3003164168

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.